OTC Pharmaceuticals Global Industry Guide_2016

Date: October 18, 2016
Pages: 271
Price:
US$ 1,495.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: O44BAA7F1FCEN
Leaflet:

Download PDF Leaflet

SUMMARY

Global OTC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the global otc pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global otc pharmaceuticals market
  • Leading company profiles reveal details of key otc pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the global otc pharmaceuticals market with five year forecasts by both value and volume
-

SYNOPSIS

Essential resource for top-line data and analysis covering the global otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends and leading companies.

REASONS TO BUY
  • What was the size of the global otc pharmaceuticals market by value in 2015?
  • What will be the size of the global otc pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the global otc pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the global otc pharmaceuticals market?
KEY HIGHLIGHTS
  • The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), medicated skin products (anti-bacterials, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters and bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2015 annual average exchange rates.
  • The global OTC pharmaceuticals market generated total revenues of $130,434.6m in 2015, representing a CARC of -1.0% between 2011 and 2015.
  • Traditional medicines registered the highest sales value in the global OTC pharmaceuticals market in 2015, with total sales of $23,987.7m, equivalent to 18.4% of the market's overall value.
  • The largest regional market globally is Asia-Pacific, although the US remains the largest individual country at 29.7% of the market in 2015.
EXECUTIVE SUMMARY

Market value
Market value forecast
Category segmentation
Geography segmentation
Market share
Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
Global OTC Pharmaceuticals
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
OTC Pharmaceuticals in Asia-Pacific
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
OTC Pharmaceuticals in Europe
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
OTC Pharmaceuticals in France
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Germany
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Italy
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Japan
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Australia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Canada
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in China
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in The Netherlands
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Spain
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in The United Kingdom
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in The United States
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Company Profiles
Leading companies
Appendix
Methodology
About MarketLine

LIST OF TABLES

Table 1: Global OTC pharmaceuticals market value: $ million, 2011-15
Table 2: Global OTC pharmaceuticals market category segmentation: $ million, 2015
Table 3: Global OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 4: Global OTC pharmaceuticals market share: % share, by value, 2015
Table 5: Global OTC pharmaceuticals market distribution: % share, by value, 2015
Table 6: Global OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 7: Asia-Pacific OTC pharmaceuticals market value: $ million, 2011-15
Table 8: Asia-Pacific OTC pharmaceuticals market category segmentation: $ million, 2015
Table 9: Asia-Pacific OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 10: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2015
Table 11: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2015
Table 12: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 13: Europe OTC pharmaceuticals market value: $ million, 2011-15
Table 14: Europe OTC pharmaceuticals market category segmentation: $ million, 2015
Table 15: Europe OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 16: Europe OTC pharmaceuticals market share: % share, by value, 2015
Table 17: Europe OTC pharmaceuticals market distribution: % share, by value, 2015
Table 18: Europe OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 19: France OTC pharmaceuticals market value: $ million, 2011-15
Table 20: France OTC pharmaceuticals market category segmentation: $ million, 2015
Table 21: France OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 22: France OTC pharmaceuticals market share: % share, by value, 2015
Table 23: France OTC pharmaceuticals market distribution: % share, by value, 2015
Table 24: France OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 25: France size of population (million), 2011-15
Table 26: France gdp (constant 2005 prices, $ billion), 2011-15
Table 27: France gdp (current prices, $ billion), 2011-15
Table 28: France inflation, 2011-15
Table 29: France consumer price index (absolute), 2011-15
Table 30: France exchange rate, 2011-15
Table 31: Germany OTC pharmaceuticals market value: $ million, 2011-15
Table 32: Germany OTC pharmaceuticals market category segmentation: $ million, 2015
Table 33: Germany OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 34: Germany OTC pharmaceuticals market share: % share, by value, 2015
Table 35: Germany OTC pharmaceuticals market distribution: % share, by value, 2015
Table 36: Germany OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 37: Germany size of population (million), 2011-15
Table 38: Germany gdp (constant 2005 prices, $ billion), 2011-15
Table 39: Germany gdp (current prices, $ billion), 2011-15
Table 40: Germany inflation, 2011-15
Table 41: Germany consumer price index (absolute), 2011-15
Table 42: Germany exchange rate, 2011-15
Table 43: Italy OTC pharmaceuticals market value: $ million, 2011-15
Table 44: Italy OTC pharmaceuticals market category segmentation: $ million, 2015
Table 45: Italy OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 46: Italy OTC pharmaceuticals market share: % share, by value, 2015
Table 47: Italy OTC pharmaceuticals market distribution: % share, by value, 2015
Table 48: Italy OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 49: Italy size of population (million), 2011-15
Table 50: Italy gdp (constant 2005 prices, $ billion), 2011-15
Table 51: Italy gdp (current prices, $ billion), 2011-15
Table 52: Italy inflation, 2011-15
Table 53: Italy consumer price index (absolute), 2011-15
Table 54: Italy exchange rate, 2011-15
Table 55: Japan OTC pharmaceuticals market value: $ million, 2011-15
Table 56: Japan OTC pharmaceuticals market category segmentation: $ million, 2015
Table 57: Japan OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 58: Japan OTC pharmaceuticals market share: % share, by value, 2015
Table 59: Japan OTC pharmaceuticals market distribution: % share, by value, 2015
Table 60: Japan OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 61: Japan size of population (million), 2011-15
Table 62: Japan gdp (constant 2005 prices, $ billion), 2011-15
Table 63: Japan gdp (current prices, $ billion), 2011-15
Table 64: Japan inflation, 2011-15
Table 65: Japan consumer price index (absolute), 2011-15
Table 66: Japan exchange rate, 2011-15
Table 67: Australia OTC pharmaceuticals market value: $ million, 2011-15
Table 68: Australia OTC pharmaceuticals market category segmentation: $ million, 2015
Table 69: Australia OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 70: Australia OTC pharmaceuticals market share: % share, by value, 2015
Table 71: Australia OTC pharmaceuticals market distribution: % share, by value, 2015
Table 72: Australia OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 73: Australia size of population (million), 2011-15
Table 74: Australia gdp (constant 2005 prices, $ billion), 2011-15
Table 75: Australia gdp (current prices, $ billion), 2011-15
Table 76: Australia inflation, 2011-15
Table 77: Australia consumer price index (absolute), 2011-15
Table 78: Australia exchange rate, 2011-15
Table 79: Canada OTC pharmaceuticals market value: $ million, 2011-15
Table 80: Canada OTC pharmaceuticals market category segmentation: $ million, 2015
Table 81: Canada OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 82: Canada OTC pharmaceuticals market share: % share, by value, 2015
Table 83: Canada OTC pharmaceuticals market distribution: % share, by value, 2015
Table 84: Canada OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 85: Canada size of population (million), 2011-15
Table 86: Canada gdp (constant 2005 prices, $ billion), 2011-15
Table 87: Canada gdp (current prices, $ billion), 2011-15
Table 88: Canada inflation, 2011-15
Table 89: Canada consumer price index (absolute), 2011-15
Table 90: Canada exchange rate, 2011-15
Table 91: China OTC pharmaceuticals market value: $ million, 2011-15
Table 92: China OTC pharmaceuticals market category segmentation: $ million, 2015
Table 93: China OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 94: China OTC pharmaceuticals market share: % share, by value, 2015
Table 95: China OTC pharmaceuticals market distribution: % share, by value, 2015
Table 96: China OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 97: China size of population (million), 2011-15
Table 98: China gdp (constant 2005 prices, $ billion), 2011-15
Table 99: China gdp (current prices, $ billion), 2011-15
Table 100: China inflation, 2011-15
Table 101: China consumer price index (absolute), 2011-15
Table 102: China exchange rate, 2011-15
Table 103: Netherlands OTC pharmaceuticals market value: $ million, 2011-15
Table 104: Netherlands OTC pharmaceuticals market category segmentation: $ million, 2015
Table 105: Netherlands OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 106: Netherlands OTC pharmaceuticals market share: % share, by value, 2015
Table 107: Netherlands OTC pharmaceuticals market distribution: % share, by value, 2015
Table 108: Netherlands OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 109: Netherlands size of population (million), 2011-15
Table 110: Netherlands gdp (constant 2005 prices, $ billion), 2011-15
Table 111: Netherlands gdp (current prices, $ billion), 2011-15
Table 112: Netherlands inflation, 2011-15
Table 113: Netherlands consumer price index (absolute), 2011-15
Table 114: Netherlands exchange rate, 2011-15
Table 115: Spain OTC pharmaceuticals market value: $ million, 2011-15
Table 116: Spain OTC pharmaceuticals market category segmentation: $ million, 2015
Table 117: Spain OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 118: Spain OTC pharmaceuticals market share: % share, by value, 2015
Table 119: Spain OTC pharmaceuticals market distribution: % share, by value, 2015
Table 120: Spain OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 121: Spain size of population (million), 2011-15
Table 122: Spain gdp (constant 2005 prices, $ billion), 2011-15
Table 123: Spain gdp (current prices, $ billion), 2011-15
Table 124: Spain inflation, 2011-15
Table 125: Spain consumer price index (absolute), 2011-15
Table 126: Spain exchange rate, 2011-15
Table 127: United Kingdom OTC pharmaceuticals market value: $ million, 2011-15
Table 128: United Kingdom OTC pharmaceuticals market category segmentation: $ million, 2015
Table 129: United Kingdom OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 130: United Kingdom OTC pharmaceuticals market share: % share, by value, 2015
Table 131: United Kingdom OTC pharmaceuticals market distribution: % share, by value, 2015
Table 132: United Kingdom OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 133: United Kingdom size of population (million), 2011-15
Table 134: United Kingdom gdp (constant 2005 prices, $ billion), 2011-15
Table 135: United Kingdom gdp (current prices, $ billion), 2011-15
Table 136: United Kingdom inflation, 2011-15
Table 137: United Kingdom consumer price index (absolute), 2011-15
Table 138: United Kingdom exchange rate, 2011-15
Table 139: United States OTC pharmaceuticals market value: $ million, 2011-15
Table 140: United States OTC pharmaceuticals market category segmentation: $ million, 2015
Table 141: United States OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 142: United States OTC pharmaceuticals market share: % share, by value, 2015
Table 143: United States OTC pharmaceuticals market distribution: % share, by value, 2015
Table 144: United States OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 145: United States size of population (million), 2011-15
Table 146: United States gdp (constant 2005 prices, $ billion), 2011-15
Table 147: United States gdp (current prices, $ billion), 2011-15
Table 148: United States inflation, 2011-15
Table 149: United States consumer price index (absolute), 2011-15
Table 150: United States exchange rate, 2011-15
Table 151: Bayer AG: key facts
Table 152: Bayer AG: key financials ($)
Table 153: Bayer AG: key financials (€)
Table 154: Bayer AG: key financial ratios
Table 155: GlaxoSmithKline Plc: key facts
Table 156: GlaxoSmithKline Plc: key financials ($)
Table 157: GlaxoSmithKline Plc: key financials (£)
Table 158: GlaxoSmithKline Plc: key financial ratios
Table 159: Johnson & Johnson: key facts
Table 160: Johnson & Johnson: key financials ($)
Table 161: Johnson & Johnson: key financial ratios
Table 162: Novartis AG: key facts
Table 163: Novartis AG: key financials ($)
Table 164: Novartis AG: key financial ratios
Table 165: Nin Jiom Medicines Manufactory Ltd: key facts
Table 166: The Procter & Gamble Company: key facts
Table 167: The Procter & Gamble Company: key financials ($)
Table 168: The Procter & Gamble Company: key financial ratios
Table 169: Reckitt Benckiser Group plc: key facts
Table 170: Reckitt Benckiser Group plc: key financials ($)
Table 171: Reckitt Benckiser Group plc: key financials (£)
Table 172: Reckitt Benckiser Group plc: key financial ratios
Table 173: Sanofi SA: key facts
Table 174: Sanofi SA: key financials ($)
Table 175: Sanofi SA: key financials (€)
Table 176: Sanofi SA: key financial ratios
Table 177: Almirall S.A.: key facts
Table 178: Almirall S.A.: key financials ($)
Table 179: Almirall S.A.: key financials (€)
Table 180: Almirall S.A.: key financial ratios
Table 181: Boehringer Ingelheim GmbH: key facts
Table 182: Boehringer Ingelheim GmbH: key financials ($)
Table 183: Boehringer Ingelheim GmbH: key financials (€)
Table 184: Boehringer Ingelheim GmbH: key financial ratios
Table 185: Daiichi Sankyo Co., Ltd.: key facts
Table 186: Daiichi Sankyo Co., Ltd.: key financials ($)
Table 187: Daiichi Sankyo Co., Ltd.: key financials (¥)
Table 188: Daiichi Sankyo Co., Ltd.: key financial ratios
Table 189: Kracie Holdings, Ltd.: key facts
Table 190: Pfizer Inc.: key facts
Table 191: Pfizer Inc.: key financials ($)
Table 192: Pfizer Inc.: key financial ratios
Table 193: Suntory Group: key facts
Table 194: Suntory Group: key financials ($)
Table 195: Suntory Group: key financials (¥)
Table 196: Suntory Group: key financial ratios
Table 197: Huangshan Tianmu Pharmaceutical Co., Ltd.: key facts

LIST OF FIGURES

Figure 1: Global OTC pharmaceuticals market value: $ million, 2011-15
Figure 2: Global OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 3: Global OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 4: Global OTC pharmaceuticals market share: % share, by value, 2015
Figure 5: Global OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 6: Global OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 7: Forces driving competition in the global OTC pharmaceuticals market, 2015
Figure 8: Drivers of buyer power in the global OTC pharmaceuticals market, 2015
Figure 9: Drivers of supplier power in the global OTC pharmaceuticals market, 2015
Figure 10: Factors influencing the likelihood of new entrants in the global OTC pharmaceuticals market, 2015
Figure 11: Factors influencing the threat of substitutes in the global OTC pharmaceuticals market, 2015
Figure 12: Drivers of degree of rivalry in the global OTC pharmaceuticals market, 2015
Figure 13: Asia-Pacific OTC pharmaceuticals market value: $ million, 2011-15
Figure 14: Asia-Pacific OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 15: Asia-Pacific OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 16: Asia-Pacific OTC pharmaceuticals market share: % share, by value, 2015
Figure 17: Asia-Pacific OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 18: Asia-Pacific OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 19: Forces driving competition in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 20: Drivers of buyer power in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 21: Drivers of supplier power in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 22: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 23: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 24: Drivers of degree of rivalry in the OTC pharmaceuticals market in Asia-Pacific, 2015
Figure 25: Europe OTC pharmaceuticals market value: $ million, 2011-15
Figure 26: Europe OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 27: Europe OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 28: Europe OTC pharmaceuticals market share: % share, by value, 2015
Figure 29: Europe OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 30: Europe OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 31: Forces driving competition in the OTC pharmaceuticals market in Europe, 2015
Figure 32: Drivers of buyer power in the OTC pharmaceuticals market in Europe, 2015
Figure 33: Drivers of supplier power in the OTC pharmaceuticals market in Europe, 2015
Figure 34: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Europe, 2015
Figure 35: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Europe, 2015
Figure 36: Drivers of degree of rivalry in the OTC pharmaceuticals market in Europe, 2015
Figure 37: France OTC pharmaceuticals market value: $ million, 2011-15
Figure 38: France OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 39: France OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 40: France OTC pharmaceuticals market share: % share, by value, 2015
Figure 41: France OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 42: France OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 43: Forces driving competition in the OTC pharmaceuticals market in France, 2015
Figure 44: Drivers of buyer power in the OTC pharmaceuticals market in France, 2015
Figure 45: Drivers of supplier power in the OTC pharmaceuticals market in France, 2015
Figure 46: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in France, 2015
Figure 47: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in France, 2015
Figure 48: Drivers of degree of rivalry in the OTC pharmaceuticals market in France, 2015
Figure 49: Germany OTC pharmaceuticals market value: $ million, 2011-15
Figure 50: Germany OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 51: Germany OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 52: Germany OTC pharmaceuticals market share: % share, by value, 2015
Figure 53: Germany OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 54: Germany OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 55: Forces driving competition in the OTC pharmaceuticals market in Germany, 2015
Figure 56: Drivers of buyer power in the OTC pharmaceuticals market in Germany, 2015
Figure 57: Drivers of supplier power in the OTC pharmaceuticals market in Germany, 2015
Figure 58: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Germany, 2015
Figure 59: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Germany, 2015
Figure 60: Drivers of degree of rivalry in the OTC pharmaceuticals market in Germany, 2015
Figure 61: Italy OTC pharmaceuticals market value: $ million, 2011-15
Figure 62: Italy OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 63: Italy OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 64: Italy OTC pharmaceuticals market share: % share, by value, 2015
Figure 65: Italy OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 66: Italy OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 67: Forces driving competition in the OTC pharmaceuticals market in Italy, 2015
Figure 68: Drivers of buyer power in the OTC pharmaceuticals market in Italy, 2015
Figure 69: Drivers of supplier power in the OTC pharmaceuticals market in Italy, 2015
Figure 70: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Italy, 2015
Figure 71: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Italy, 2015
Figure 72: Drivers of degree of rivalry in the OTC pharmaceuticals market in Italy, 2015
Figure 73: Japan OTC pharmaceuticals market value: $ million, 2011-15
Figure 74: Japan OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 75: Japan OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 76: Japan OTC pharmaceuticals market share: % share, by value, 2015
Figure 77: Japan OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 78: Japan OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 79: Forces driving competition in the OTC pharmaceuticals market in Japan, 2015
Figure 80: Drivers of buyer power in the OTC pharmaceuticals market in Japan, 2015
Figure 81: Drivers of supplier power in the OTC pharmaceuticals market in Japan, 2015
Figure 82: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Japan, 2015
Figure 83: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Japan, 2015
Figure 84: Drivers of degree of rivalry in the OTC pharmaceuticals market in Japan, 2015
Figure 85: Australia OTC pharmaceuticals market value: $ million, 2011-15
Figure 86: Australia OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 87: Australia OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 88: Australia OTC pharmaceuticals market share: % share, by value, 2015
Figure 89: Australia OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 90: Australia OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 91: Forces driving competition in the OTC pharmaceuticals market in Australia, 2015
Figure 92: Drivers of buyer power in the OTC pharmaceuticals market in Australia, 2015
Figure 93: Drivers of supplier power in the OTC pharmaceuticals market in Australia, 2015
Figure 94: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Australia, 2015
Figure 95: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Australia, 2015
Figure 96: Drivers of degree of rivalry in the OTC pharmaceuticals market in Australia, 2015
Figure 97: Canada OTC pharmaceuticals market value: $ million, 2011-15
Figure 98: Canada OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 99: Canada OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 100: Canada OTC pharmaceuticals market share: % share, by value, 2015
Figure 101: Canada OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 102: Canada OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 103: Forces driving competition in the OTC pharmaceuticals market in Canada, 2015
Figure 104: Drivers of buyer power in the OTC pharmaceuticals market in Canada, 2015
Figure 105: Drivers of supplier power in the OTC pharmaceuticals market in Canada, 2015
Figure 106: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Canada, 2015
Figure 107: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Canada, 2015
Figure 108: Drivers of degree of rivalry in the OTC pharmaceuticals market in Canada, 2015
Figure 109: China OTC pharmaceuticals market value: $ million, 2011-15
Figure 110: China OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 111: China OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 112: China OTC pharmaceuticals market share: % share, by value, 2015
Figure 113: China OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 114: China OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 115: Forces driving competition in the OTC pharmaceuticals market in China, 2015
Figure 116: Drivers of buyer power in the OTC pharmaceuticals market in China, 2015
Figure 117: Drivers of supplier power in the OTC pharmaceuticals market in China, 2015
Figure 118: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in China, 2015
Figure 119: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in China, 2015
Figure 120: Drivers of degree of rivalry in the OTC pharmaceuticals market in China, 2015
Figure 121: Netherlands OTC pharmaceuticals market value: $ million, 2011-15
Figure 122: Netherlands OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 123: Netherlands OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 124: Netherlands OTC pharmaceuticals market share: % share, by value, 2015
Figure 125: Netherlands OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 126: Netherlands OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 127: Forces driving competition in the OTC pharmaceuticals market in the Netherlands, 2015
Figure 128: Drivers of buyer power in the OTC pharmaceuticals market in the Netherlands, 2015
Figure 129: Drivers of supplier power in the OTC pharmaceuticals market in the Netherlands, 2015
Figure 130: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in the Netherlands, 2015
Figure 131: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in the Netherlands, 2015
Figure 132: Drivers of degree of rivalry in the OTC pharmaceuticals market in the Netherlands, 2015
Figure 133: Spain OTC pharmaceuticals market value: $ million, 2011-15
Figure 134: Spain OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 135: Spain OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 136: Spain OTC pharmaceuticals market share: % share, by value, 2015
Figure 137: Spain OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 138: Spain OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 139: Forces driving competition in the OTC pharmaceuticals market in Spain, 2015
Figure 140: Drivers of buyer power in the OTC pharmaceuticals market in Spain, 2015
Figure 141: Drivers of supplier power in the OTC pharmaceuticals market in Spain, 2015
Figure 142: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Spain, 2015
Figure 143: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Spain, 2015
Figure 144: Drivers of degree of rivalry in the OTC pharmaceuticals market in Spain, 2015
Figure 145: United Kingdom OTC pharmaceuticals market value: $ million, 2011-15
Figure 146: United Kingdom OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 147: United Kingdom OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 148: United Kingdom OTC pharmaceuticals market share: % share, by value, 2015
Figure 149: United Kingdom OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 150: United Kingdom OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 151: Forces driving competition in the OTC pharmaceuticals market in the United Kingdom, 2015
Figure 152: Drivers of buyer power in the OTC pharmaceuticals market in the United Kingdom, 2015
Figure 153: Drivers of supplier power in the OTC pharmaceuticals market in the United Kingdom, 2015
Figure 154: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in the United Kingdom, 2015
Figure 155: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in the United Kingdom, 2015
Figure 156: Drivers of degree of rivalry in the OTC pharmaceuticals market in the United Kingdom, 2015
Figure 157: United States OTC pharmaceuticals market value: $ million, 2011-15
Figure 158: United States OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 159: United States OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 160: United States OTC pharmaceuticals market share: % share, by value, 2015
Figure 161: United States OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 162: United States OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 163: Forces driving competition in the OTC pharmaceuticals market in the United States, 2015
Figure 164: Drivers of buyer power in the OTC pharmaceuticals market in the United States, 2015
Figure 165: Drivers of supplier power in the OTC pharmaceuticals market in the United States, 2015
Figure 166: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in the United States, 2015
Figure 167: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in the United States, 2015
Figure 168: Drivers of degree of rivalry in the OTC pharmaceuticals market in the United States, 2015
Figure 169: Bayer AG: revenues & profitability
Figure 170: Bayer AG: assets & liabilities
Figure 171: GlaxoSmithKline Plc: revenues & profitability
Figure 172: GlaxoSmithKline Plc: assets & liabilities
Figure 173: Johnson & Johnson: revenues & profitability
Figure 174: Johnson & Johnson: assets & liabilities
Figure 175: Novartis AG: revenues & profitability
Figure 176: Novartis AG: assets & liabilities
Figure 177: The Procter & Gamble Company: revenues & profitability
Figure 178: The Procter & Gamble Company: assets & liabilities
Figure 179: Reckitt Benckiser Group plc: revenues & profitability
Figure 180: Reckitt Benckiser Group plc: assets & liabilities
Figure 181: Sanofi SA: revenues & profitability
Figure 182: Sanofi SA: assets & liabilities
Figure 183: Almirall S.A.: revenues & profitability
Figure 184: Almirall S.A.: assets & liabilities
Figure 185: Boehringer Ingelheim GmbH: revenues & profitability
Figure 186: Boehringer Ingelheim GmbH: assets & liabilities
Figure 187: Daiichi Sankyo Co., Ltd.: revenues & profitability
Figure 188: Daiichi Sankyo Co., Ltd.: assets & liabilities
Figure 189: Pfizer Inc.: revenues & profitability
Figure 190: Pfizer Inc.: assets & liabilities
Figure 191: Suntory Group: revenues & profitability
Figure 192: Suntory Group: assets & liabilities
Skip to top


US OTC Pharmaceutical Market Guide US$ 197.00 Nov, 2012 · 62 pages
OTC Pharmaceuticals in North America US$ 350.00 Sep, 2016 · 37 pages
OTC Pharmaceuticals in Scandinavia US$ 350.00 Sep, 2016 · 37 pages
OTC Pharmaceuticals in Indonesia US$ 350.00 Sep, 2016 · 37 pages

Ask Your Question

OTC Pharmaceuticals Global Industry Guide_2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: